Cargando…
Casting a Wider NET: Pancreatic Exocrine Insufficiency Induced by Somatostatin Analogues among Patients with Neuroendocrine Tumours?
SIMPLE SUMMARY: Somatostatin analogues (SSA) are used to treat patients with unresectable neuroendocrine tumours (NET). An underrecognized side-effect of SSAs is pancreatic exocrine insufficiency (PEI), where the pancreas is unable to maintain the normal digestion of food. Whilst the few papers that...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093494/ https://www.ncbi.nlm.nih.gov/pubmed/37046594 http://dx.doi.org/10.3390/cancers15071933 |